FTC Sues to Block Amgen’s Acquisition of Horizon Therapeutics
The Federal Trade Commission is suing to block Amgen Inc.’s $28 billion acquisition of Horizon Therapeutics to prevent a monopoly in the market for d.rugs that treat critical ailments
Symbol | Last Price | Change | % Change |
---|---|---|---|